T1	Participants 164 267	May 1978 until November 1980, 169 previously untreated patients with advanced epithelial ovarian cancer
T2	Participants 570 724	153 patients evaluable for response, there were 47, or 30.7%, complete responders (all determined surgically), 6 partial responders, and 100 nonresponders
